FDA Investigator Lisa R Hilliar

Lisa R Hilliar has inspections in 4 countries as of 08 Dec 2023. Lisa R Hilliar has collaborated with a combinined 1811 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
21
Last Inspection Date:
08 Dec 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100002251
Country:
United States of America, Japan, India, Israel
Co-Investigator(s):
Aditi S Thakur, Alan M Barker, Allison C Hunter, Andrea A Branche, Andrew J Barrowcliff, Anna M Brannen, Bei Y He, Brenda C Hamilton, Carl Lee, Cassandra L Abellard, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles L Zhou, Christina L Bigham, Christopher T Middendorf, Claire M Minden, Constantin Y Philopoulos, D Yvette Barnett, David S Jackson, Dipesh K Shah, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Dyvette Arline, Elizabeth Ll Edwards, Gayle S Lawson, Genevieve E Ghand, Geoffrey K Kilili, Gretchen Lf Trendel, Heather A Mccauley, Hector A Carrero, Isabel Y Espinosa, James C Maclaughlin, James Norman, Jamie L Dion, Javonica F Penn, Jeffrey D Meng, Jennifer L Gustavus, Jessica L Pressley, Jill R Loeliger, Jill R Raezer, Jon P Antoniou, Jose E Melendez, DDC, Joseph A Piechocki, Joshua P Wireman, Joshua S Hunt, Juan Rjimenez Garcia, Junho Pak, Kathleen D Culver, Kathleen Dant Ceckner, Kenneth E Felkley, Kenneth H Williams, Kham Phommachanh, Lauren N Howard, Lauren N Smith, Lianji Jin, Linda F Murphy, Lindsey M Schwierjohann, Logan T Williams, Luis M Burgos Medero, Marcellinus D Dordunoo, Margaret M Annes, Maribeth G Grattan, Mark E Parmon, Matthew B Casale, Megan T Ziegler, Michael C Zubelewicz, Michael P Sheehan, Michele L Forster, PhD, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nibin Varghese, MS, Nicholas J Presto, Nicholas L Paulin, Nimmy Mathews, Nina Ni, Ou Ma, Paranthaman Senthamaraikannan, Peter E Baker, Rafeeq A Habeeb, Rebecca E Dombrowski, Robert J Ham, Roy C Stephens, Samantha J Bradley, Sena G Dissmeyer, Senz G Dissmeyer, Steven P Eastham, Susan M Jackson, Sydney S Choi, Tamil Arasu, PhD, Teresa K Kastner, Thomas J Arista, Tiara M Brown, Tracey L Harris, Vaishali J Patel, Walden H Lee, Wayne D Mcgrath, Wen Ning Chan (Sally), Wendy G Tan, PhD, Zachary L Miller

Lisa R Hilliar's Documents

Publish Date Document Type Title
June, 2022 FDA 483 Bullet Line, LLC - Form 483, 2022-06-10
March, 2022 FDA 483 Response TMC Acquisitions LLC dba Tailor Made Compounding - Form 483R, 2022-04-04
May, 2021 EIR Sterling Pharmaceutical Services, LLC - EIR, 2021-05-14
July, 2021 FDA 483 Grand River Aseptic Manufacturing Inc - Form 483, 2021-07-02
July, 2021 EIR Grand River Aseptic Manufacturing Inc - EIR, 2021-07-02
November, 2021 FDA 483 Miami University - Form 483, 2021-11-05
August, 2022 FDA 483 Lambda Research, Inc. - Form 483, 2022-08-26
March, 2022 FDA 483 TMC Acquisitions LLC dba Tailor Made Compounding - Form 483, 2022-03-14
November, 2021 FDA 483 Response Miami University - Form 483R, 2021-11-29
May, 2023 FDA 483 SCA Pharmaceuticals, Inc. - Form 483, 2023-05-17
February, 2022 FDA 483 Xellia Pharmaceuticals USA LLC - Form 483, 2022-02-07
May, 2022 FDA 483 Kinbio LTD - Form 483, 2022-05-26
March, 2023 FDA 483 Greene Respiratory Services, Inc - Form 483, 2023-03-31
December, 2022 FDA 483 Xellia Pharmaceuticals USA LLC - Form 483, 2022-12-15
August, 2021 FDA 483 CASAD Company, Inc. - Form 483, 2021-08-18
July, 2021 FDA 483 Response Grand River Aseptic Manufacturing Inc - Form 483R, 2021-07-26
May, 2021 FDA 483 Sterling Pharmaceutical Services, LLC - Form 483, 2021-05-14
December, 2023 FDA 483 Pharmalogic Cincinnati, LLC - Form 483, 2023-12-08
June, 2023 FDA 483 Vantage Specialty Ingredients, Inc. - Form 483, 2023-06-27
September, 2023 FDA 483 STELLA CHEMIFA CORPORATION - Form 483, 2023-09-22
January, 2024 FDA 483 POET BIOREFINING - LEIPSIC, LLC - Form 483, 2024-01-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more